Today: 8 June 2026
Browse Category

OTC:CNSWF 10 November 2025

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

CSU Stock Today (Nov 10, 2025): Constellation Software Hits New 52‑Week Low as BMO Trims Target; Q3 Revenue +16% and $1 Dividend Reaffirmed

Constellation Software shares hit a new 52-week low Monday, trading near C$3,262 on the TSX after BMO Capital cut its price target to C$4,600 and Q3 revenue missed consensus. Q3 revenue rose 16% to US$2.948 billion, with net income at US$210 million. The S&P/TSX Composite gained 1.1% intraday, highlighting CSU’s stock-specific decline. The board reaffirmed a US$1.00 quarterly dividend.
10 November 2025
···

Stock Market Today

  • Altimeter Capital CEO Warns Traders on Potential Risks Ahead of SpaceX IPO
    June 8, 2026, 9:46 AM EDT. Brad Gerstner, CEO of Altimeter Capital, cautioned retail investors about challenges in upcoming big tech IPOs, including the anticipated SpaceX public offering. Gerstner highlighted that these initial public offerings (IPOs) could pose risks due to market volatility and heightened investor scrutiny. His warning signals the need for careful analysis as SpaceX, a major space exploration and satellite internet company, prepares to enter public markets. Investors are advised to stay alert amid these developments to navigate potential pitfalls.

Latest articles

Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
Go toTop